Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
2009 · Nature · 4,063 citations
https://doi.org/10.1038/nature08460
S
Susan E. Moody
Broad Institute(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
114
Papers
8.7K
Citations
28
h-index
36
i10-index
Susan E. Moody is an academic researcher from Broad Institute. The author has contributed to research in topics: Protein Tyrosine Phosphatases & Melanoma and MAPK Pathways & Synthesis and biological activity. The author has an h-index of 28, co-authored 97 publications.
ORCID: 0009-0002-7714-1170Papers by this author
worksThe transcriptional repressor Snail promotes mammary tumor recurrence
2005 · Cancer Cell · 723 citations
https://doi.org/10.1016/j.ccr.2005.07.009
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
2007 · Nature Cell Biology · 486 citations
https://doi.org/10.1038/ncb1567
PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling
2014 · Oncogene · 116 citations
https://doi.org/10.1038/onc.2014.153
Induction of Neuregulin Signaling in Mouse Schwann Cells In Vivo Mimics Responses to Denervation
2006 · Journal of Neuroscience · 85 citations
https://doi.org/10.1523/jneurosci.1086-06.2006
Cellular dormancy in minimal residual disease following targeted therapy
2021 · Breast Cancer Research · 43 citations
https://doi.org/10.1186/s13058-021-01416-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat